RxDoctor Payments Data

Andrew Lamm, PA

Physician Assistant · Anchorage, AKNPI 1477035947

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (59.3%), food and beverage and education — rather than concentrated in one kind of arrangement. Medical Device Business Services, Inc. accounts for 77.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $2,385, more than ten times the $125 reported in 2023. Among physician assistant clinicians in AK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,614in general payments, 2019–2025

Across 26 payments — averaging $100.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • Johnson & Johnson$177
  • Heron Therapeutics, Inc.$125
  • Stryker$90
  • Solventum Corporation$88
  • Bioventus LLC$32
  • plus $81 from 4 others

What the payments were for

  • Travel & lodging$1,54959%
  • Food & beverage$92835%
  • Education$1375%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,614 in reported general payments places this provider in the 90th percentile of 365 physician assistant providers in Alaska.

See all physician assistant providers in Alaska

Medicare billing

Part B allowed, 2024
$123,596
Medicare patients
355
Services billed
8,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban37$16,823
Ondansetron OdtOndansetron99$1,388
Celecoxib105$1,034
Cyclobenzaprine Hcl117$803
Oxycodone Hcl121$760
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$686
Gabapentin132$439
Tramadol Hcl131$345
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen19$148
Cephalexin23$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$177$16,82337 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 365 physician assistant providers in Alaska.

Other physician assistant in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →